NantHealth, Inc. (NH)
| Previous close | 1.3500 |
| Open | 1.2900 |
| Bid | 1.2400 x 800 |
| Ask | 1.4800 x 900 |
| Day's range | 1.2700 - 1.3700 |
| 52-week range | 1.2500 - 6.6000 |
| Volume | 46,323 |
| Avg. volume | 115,833 |
| Market cap | 150.078M |
| Beta (5Y monthly) | 1.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5490 |
| Earnings date | 23 Feb 2022 - 28 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.50 |
- Simply Wall St.
How Many NantHealth, Inc. (NASDAQ:NH) Shares Do Institutions Own?
If you want to know who really controls NantHealth, Inc. ( NASDAQ:NH ), then you'll have to look at the makeup of its...
- Business Wire
Maryland Physicians Care (MPC) Selects NantHealth’s Eviti Connect to Validate Treatment For Members with Autoimmune Diseases
MORRISVILLE, N.C., November 16, 2021--NantHealth, Inc. (NASDAQ: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that Maryland Physicians Care (MPC), an existing customer of the Eviti Connect for Oncology platform, selected NantHealth’s Eviti Connect for Autoimmune Diseases solution as the foundation for MPC’s new industry-leading digital drug authorization program for members living with chronic autoimmune cond
- Motley Fool
NantHealth, Inc. Common Stock (NH) Q3 2021 Earnings Call Transcript
Image source: The Motley Fool. NantHealth, Inc. Common Stock (NASDAQ: NH)Q3 2021 Earnings CallNov 04, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGreetings and welcome to the NantHealth Inc.
